Skip to main content
Erschienen in: Obesity Surgery 2/2020

23.10.2019 | Original Contributions

The Long-term Impact of Roux-en-Y Gastric Bypass on Colorectal Polyp Formation and Relation to Weight Loss Outcomes

verfasst von: Hisham Hussan, Alyssa Drosdak, Melissa Le Roux, Kishan Patel, Kyle Porter, Steven K. Clinton, Brian Focht, Sabrena Noria

Erschienen in: Obesity Surgery | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Evolving epidemiological data, backed by mechanistic evidence, supports a paradoxical increase in the risk of colorectal cancer after Roux-en-Y gastric bypass surgery (RYGB). We examined the risk of colonic polyps after RYGB.

Methods

A single-center retrospective study included colonoscopies performed between the years 1994 and 2018. To focus on the long-term impact of RYGB on precancerous colonic polyps, we compared patients at average risk for CRC who underwent colonoscopy ≥ 5 years after RYGB (n = 86) versus pre-RYGB (n = 106). We analyzed our data using inverse probability of treatment weighting (IPTW) using propensity scores in order to account for multiple potential confounders.

Results

After IPTW, we found no statistical differences between pre- and post-RYGB patients for risk of any polyp (33.2% pre- vs. 32.7% post-RYGB). However, the percentage of serrated polyps was higher ≥ 5 years post-RYGB compared with pre-RYGB (8.7% vs. 2.1%, p = 0.04, relative risk = 4.22; 95% CI 0.97, 18.4). Body mass index ≥ 30 kg/m2 at time of colonoscopy was associated with a greater risk for any polyp after RYGB (OR 6.23; 95% CI 1.16, 33.41). There was also a trend towards increased risk of polyps in post-RYGB patients who were current smokers (OR = 4.97; 95% CI 0.82, 30) or with age > 55 years (OR = 2.49; 95% CI 0.88, 7.00).

Conclusion

Our data suggest that RYGB is associated with an increased risk of serrated polyps after 5 years from surgery. Prospective studies defining this risk and examining mechanisms will be instrumental for application of CRC preventative strategies in this population.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer. J Clin Densitom. 2017;67(3):177–93. Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer. J Clin Densitom. 2017;67(3):177–93.
2.
Zurück zum Zitat Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci. 2011;1229:45–52.PubMedCrossRef Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci. 2011;1229:45–52.PubMedCrossRef
3.
Zurück zum Zitat Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352(18):1851–60.PubMedCrossRef Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352(18):1851–60.PubMedCrossRef
4.
Zurück zum Zitat Worthley DL, Leggett BA. Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev. 2010;31(2):31–8.PubMedPubMedCentral Worthley DL, Leggett BA. Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev. 2010;31(2):31–8.PubMedPubMedCentral
5.
Zurück zum Zitat Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338(21):1481–7.PubMedCrossRef Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338(21):1481–7.PubMedCrossRef
6.
Zurück zum Zitat Devaud N, Gallinger S. Chemotherapy of MMR-deficient colorectal cancer. Familial Cancer. 2013;12(2):301–6.PubMedCrossRef Devaud N, Gallinger S. Chemotherapy of MMR-deficient colorectal cancer. Familial Cancer. 2013;12(2):301–6.PubMedCrossRef
7.
8.
Zurück zum Zitat Kang S, Na Y, Joung SY, et al. The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors. Medicine. 2018;97(9):–e0019.PubMedPubMedCentralCrossRef Kang S, Na Y, Joung SY, et al. The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors. Medicine. 2018;97(9):–e0019.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Cisyk AL, Singh H, McManus KJ. Establishing a biological profile for interval colorectal cancers. Dig Dis Sci. 2014;59(10):2390–402.PubMedCrossRef Cisyk AL, Singh H, McManus KJ. Establishing a biological profile for interval colorectal cancers. Dig Dis Sci. 2014;59(10):2390–402.PubMedCrossRef
11.
Zurück zum Zitat Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013;144(1):74–80.e71.PubMedCrossRef Pohl H, Srivastava A, Bensen SP, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013;144(1):74–80.e71.PubMedCrossRef
12.
Zurück zum Zitat le Clercq CM, Bouwens MW, Rondagh EJ, et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut. 2014;63(6):957–63.PubMedCrossRef le Clercq CM, Bouwens MW, Rondagh EJ, et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut. 2014;63(6):957–63.PubMedCrossRef
13.
Zurück zum Zitat Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology. 2012;142(4):762–72.PubMedCrossRef Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology. 2012;142(4):762–72.PubMedCrossRef
14.
15.
Zurück zum Zitat Okabayashi K, Ashrafian H, Hasegawa H, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107(8):1175–85. quiz 1186PubMedCrossRef Okabayashi K, Ashrafian H, Hasegawa H, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107(8):1175–85. quiz 1186PubMedCrossRef
16.
Zurück zum Zitat Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86(3):556–65.PubMedCrossRef Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86(3):556–65.PubMedCrossRef
17.
Zurück zum Zitat He X, Wu K, Ogino S, et al. Association between risk factors for colorectal cancer and risk of serrated polyps and conventional adenomas. Gastroenterology. 2018;155(2):355–373.e318.PubMedCrossRef He X, Wu K, Ogino S, et al. Association between risk factors for colorectal cancer and risk of serrated polyps and conventional adenomas. Gastroenterology. 2018;155(2):355–373.e318.PubMedCrossRef
18.
Zurück zum Zitat Afshar S, Kelly SB, Seymour K, et al. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg. 2014;24(10):1793–9.PubMedCrossRef Afshar S, Kelly SB, Seymour K, et al. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg. 2014;24(10):1793–9.PubMedCrossRef
19.
Zurück zum Zitat Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101.PubMedCrossRef Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101.PubMedCrossRef
20.
Zurück zum Zitat Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17(4):796–802.CrossRef Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17(4):796–802.CrossRef
21.
Zurück zum Zitat Derogar M, Hull MA, Kant P, et al. Increased risk of colorectal cancer after obesity surgery. Ann Surg. 2013;258(6):983–8.PubMedCrossRef Derogar M, Hull MA, Kant P, et al. Increased risk of colorectal cancer after obesity surgery. Ann Surg. 2013;258(6):983–8.PubMedCrossRef
22.
23.
Zurück zum Zitat Ostlund MP, Lu Y, Lagergren J. Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg. 2010;252(6):972–6.PubMedCrossRef Ostlund MP, Lu Y, Lagergren J. Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg. 2010;252(6):972–6.PubMedCrossRef
24.
Zurück zum Zitat Hussan H, Stanich PP, Gray 2nd DM, et al. Prior bariatric surgery is linked to improved colorectal cancer surgery outcomes and costs: a propensity-matched analysis. Obes Surg. 2017;27(4):1047–55.PubMedCrossRef Hussan H, Stanich PP, Gray 2nd DM, et al. Prior bariatric surgery is linked to improved colorectal cancer surgery outcomes and costs: a propensity-matched analysis. Obes Surg. 2017;27(4):1047–55.PubMedCrossRef
25.
Zurück zum Zitat Kant P, Sainsbury A, Reed KR, et al. Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB. Gut. 2011;60(7):893–901.PubMedCrossRef Kant P, Sainsbury A, Reed KR, et al. Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB. Gut. 2011;60(7):893–901.PubMedCrossRef
26.
Zurück zum Zitat Sainsbury A, Goodlad RA, Perry SL, et al. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass. Cancer Epidemiol Biomarkers Prev. 2008;17(6):1401–10.PubMedCrossRef Sainsbury A, Goodlad RA, Perry SL, et al. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass. Cancer Epidemiol Biomarkers Prev. 2008;17(6):1401–10.PubMedCrossRef
27.
Zurück zum Zitat Mills SJ, Mathers JC, Chapman PD, et al. Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut. 2001;48(1):41–6.PubMedPubMedCentralCrossRef Mills SJ, Mathers JC, Chapman PD, et al. Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut. 2001;48(1):41–6.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Gordon-Weeks AN, Lim SY, Yuzhalin AE, et al. Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer. Cytokine Growth Factor Rev. 2015. Gordon-Weeks AN, Lim SY, Yuzhalin AE, et al. Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer. Cytokine Growth Factor Rev. 2015.
29.
Zurück zum Zitat Li JV, Reshat R, Wu Q, et al. Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol. 2011;2:183.PubMedPubMedCentral Li JV, Reshat R, Wu Q, et al. Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol. 2011;2:183.PubMedPubMedCentral
30.
Zurück zum Zitat Afshar S, Malcomson F, Kelly SB, et al. Biomarkers of colorectal cancer risk decrease 6 months after Roux-en-Y gastric bypass surgery. Obes Surg. 2018;28(4):945–54.PubMedCrossRef Afshar S, Malcomson F, Kelly SB, et al. Biomarkers of colorectal cancer risk decrease 6 months after Roux-en-Y gastric bypass surgery. Obes Surg. 2018;28(4):945–54.PubMedCrossRef
31.
Zurück zum Zitat Kedrin D, Gandhi SC, Wolf M, et al. Bariatric surgery prior to index screening colonoscopy is associated with a decreased rate of colorectal adenomas in obese individuals. Clin Transl Gastroenterol. 2017;8(2):e73.PubMedPubMedCentralCrossRef Kedrin D, Gandhi SC, Wolf M, et al. Bariatric surgery prior to index screening colonoscopy is associated with a decreased rate of colorectal adenomas in obese individuals. Clin Transl Gastroenterol. 2017;8(2):e73.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Helfand M, Marton KI, Zimmer-Gembeck MJ, et al. History of visible rectal bleeding in a primary care population: initial assessment and 10-year follow-up. JAMA. 1997;277(1):44–8.PubMedCrossRef Helfand M, Marton KI, Zimmer-Gembeck MJ, et al. History of visible rectal bleeding in a primary care population: initial assessment and 10-year follow-up. JAMA. 1997;277(1):44–8.PubMedCrossRef
33.
Zurück zum Zitat Schoen RE, Corle D, Cranston L, et al. Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial. Gastroenterology. 1998;115(3):533–41.PubMedCrossRef Schoen RE, Corle D, Cranston L, et al. Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial. Gastroenterology. 1998;115(3):533–41.PubMedCrossRef
34.
Zurück zum Zitat Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–79.PubMedPubMedCentralCrossRef Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–79.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Colorectal cancer 2011 report Food, nutrition, physical activity, and the prevention of colorectal cancer Colorectal cancer 2011 report Food, nutrition, physical activity, and the prevention of colorectal cancer
36.
Zurück zum Zitat Neto RML, Herbella FAM, Tauil RM, et al. Comorbidities remission after Roux-en-Y gastric bypass for morbid obesity is sustained in a long-term follow-up and correlates with weight regain. Obes Surg. 2012;22(10):1580–5.CrossRef Neto RML, Herbella FAM, Tauil RM, et al. Comorbidities remission after Roux-en-Y gastric bypass for morbid obesity is sustained in a long-term follow-up and correlates with weight regain. Obes Surg. 2012;22(10):1580–5.CrossRef
37.
Zurück zum Zitat Anderson JC, Butterly LF, Weiss JE, et al. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2017;85(6):1188–94.PubMedPubMedCentralCrossRef Anderson JC, Butterly LF, Weiss JE, et al. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2017;85(6):1188–94.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Lieberman DA, Williams JL, Holub JL, et al. Race, ethnicity, and sex affect risk for polyps >9 mm in average-risk individuals. Gastroenterology. 2014;147(2):351–8. quiz e314-355PubMedCrossRef Lieberman DA, Williams JL, Holub JL, et al. Race, ethnicity, and sex affect risk for polyps >9 mm in average-risk individuals. Gastroenterology. 2014;147(2):351–8. quiz e314-355PubMedCrossRef
39.
Zurück zum Zitat Heitman SJ, Ronksley PE, Hilsden RJ, et al. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7(12):1272–8.PubMedCrossRef Heitman SJ, Ronksley PE, Hilsden RJ, et al. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7(12):1272–8.PubMedCrossRef
40.
Zurück zum Zitat Tao W, Konings P, Hull MA, et al. Colorectal cancer prognosis following obesity surgery in a population-based cohort study. Obes Surg. 2016. Tao W, Konings P, Hull MA, et al. Colorectal cancer prognosis following obesity surgery in a population-based cohort study. Obes Surg. 2016.
41.
Zurück zum Zitat Karahalios A, English DR, Simpson JA. Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol. 2015;181(11):832–45.PubMedCrossRef Karahalios A, English DR, Simpson JA. Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol. 2015;181(11):832–45.PubMedCrossRef
42.
Zurück zum Zitat Freire RH, Borges MC, Alvarez-Leite JI, et al. Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass. Nutrition. 2012;28(1):53–8.PubMedCrossRef Freire RH, Borges MC, Alvarez-Leite JI, et al. Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass. Nutrition. 2012;28(1):53–8.PubMedCrossRef
43.
Zurück zum Zitat Christou NV, Look D, MacLean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244(5):734–40.PubMedPubMedCentralCrossRef Christou NV, Look D, MacLean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244(5):734–40.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Karmali S, Brar B, Shi X, et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg. 2013;23(11):1922–33.PubMedCrossRef Karmali S, Brar B, Shi X, et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg. 2013;23(11):1922–33.PubMedCrossRef
45.
Zurück zum Zitat Sarwer DB, Wadden TA, Moore RH, et al. Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery. Surg Obes Relat Dis. 2008;4(5):640–6.PubMedPubMedCentralCrossRef Sarwer DB, Wadden TA, Moore RH, et al. Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery. Surg Obes Relat Dis. 2008;4(5):640–6.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Maleckas A, Gudaitytė R, Petereit R, et al. Weight regain after gastric bypass: etiology and treatment options. Gland Surg. 2016;5(6):617–24. 10/16/receive d 11/18/acceptedPubMedPubMedCentralCrossRef Maleckas A, Gudaitytė R, Petereit R, et al. Weight regain after gastric bypass: etiology and treatment options. Gland Surg. 2016;5(6):617–24. 10/16/receive d 11/18/acceptedPubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Research WCRFaAifC. Nutrition, physical activity and cancer: a global perspective: a summary of the third expert report. Washington: DC;2018. Research WCRFaAifC. Nutrition, physical activity and cancer: a global perspective: a summary of the third expert report. Washington: DC;2018.
48.
Zurück zum Zitat Mukorako P, Lopez C, Baraboi E-D, et al. Alterations of gut microbiota after biliopancreatic diversion with duodenal switch in Wistar rats. Obes Surg. 2019;29:2831–42.PubMedCrossRef Mukorako P, Lopez C, Baraboi E-D, et al. Alterations of gut microbiota after biliopancreatic diversion with duodenal switch in Wistar rats. Obes Surg. 2019;29:2831–42.PubMedCrossRef
49.
Zurück zum Zitat Anhe FF, Varin TV, Schertzer JD, et al. The gut microbiota as a mediator of metabolic benefits after bariatric surgery. Can J Diabetes. 2017. Anhe FF, Varin TV, Schertzer JD, et al. The gut microbiota as a mediator of metabolic benefits after bariatric surgery. Can J Diabetes. 2017.
50.
Zurück zum Zitat Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22(2):228–38.PubMedPubMedCentralCrossRef Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22(2):228–38.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Guo Y, Liu CQ, Shan CX, et al. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: increased diversity and associations of discriminant genera with metabolic changes. Diabetes Metab Res Rev. 2017;33(3)CrossRef Guo Y, Liu CQ, Shan CX, et al. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: increased diversity and associations of discriminant genera with metabolic changes. Diabetes Metab Res Rev. 2017;33(3)CrossRef
52.
Zurück zum Zitat Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016;8:67. 06/15 01/11/received 05/04/acceptedPubMedPubMedCentralCrossRef Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016;8:67. 06/15 01/11/received 05/04/acceptedPubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Shao Y, Ding R, Xu B, et al. Alterations of gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in Sprague-Dawley rats. Obes Surg. 2017;27(2):295–302.PubMedCrossRef Shao Y, Ding R, Xu B, et al. Alterations of gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in Sprague-Dawley rats. Obes Surg. 2017;27(2):295–302.PubMedCrossRef
54.
Zurück zum Zitat Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509(7499):183–8.PubMedPubMedCentralCrossRef Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509(7499):183–8.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Damms-Machado A, Mitra S. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. 2015;2015:806248. Damms-Machado A, Mitra S. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. 2015;2015:806248.
56.
Zurück zum Zitat Aron-Wisnewsky J, Prifti E, Belda E, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2018. Aron-Wisnewsky J, Prifti E, Belda E, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2018.
57.
Zurück zum Zitat Andoh A, Nishida A, Takahashi K, et al. Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population. J Clin Biochem Nutr. 2016;59(1):65–70.PubMedPubMedCentralCrossRef Andoh A, Nishida A, Takahashi K, et al. Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population. J Clin Biochem Nutr. 2016;59(1):65–70.PubMedPubMedCentralCrossRef
58.
Zurück zum Zitat Sillakivi T, Suumann J, Kirsimagi U, et al. Plasma levels of gastric biomarkers in patients after bariatric surgery: biomarkers after bariatric surgery. Hepatogastroenterology. 2013;60(128):2129–32.PubMed Sillakivi T, Suumann J, Kirsimagi U, et al. Plasma levels of gastric biomarkers in patients after bariatric surgery: biomarkers after bariatric surgery. Hepatogastroenterology. 2013;60(128):2129–32.PubMed
59.
Zurück zum Zitat Morinigo R, Moize V, Musri M, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2006;91(5):1735–40.PubMedCrossRef Morinigo R, Moize V, Musri M, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2006;91(5):1735–40.PubMedCrossRef
60.
Zurück zum Zitat Smith CD, Herkes SB, Behrns KE, et al. Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 1993;218(1):91–6.PubMedPubMedCentralCrossRef Smith CD, Herkes SB, Behrns KE, et al. Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 1993;218(1):91–6.PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Hussan H, Clinton SK, Roberts K, et al. Fusobacterium’s link to colorectal neoplasia sequenced: a systematic review and future insights. World J Gastroenterol. 2017;23(48):8626–50.PubMedPubMedCentralCrossRef Hussan H, Clinton SK, Roberts K, et al. Fusobacterium’s link to colorectal neoplasia sequenced: a systematic review and future insights. World J Gastroenterol. 2017;23(48):8626–50.PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat O'Keefe SJ, Li JV, Lahti L. Fat, fibre and cancer risk in African Americans and rural Africans 2015;6:6342. O'Keefe SJ, Li JV, Lahti L. Fat, fibre and cancer risk in African Americans and rural Africans 2015;6:6342.
63.
Zurück zum Zitat Kantor ED, Udumyan R, Signorello LB, et al. Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk. Gut. 2016;65(8):1289–95.PubMedCrossRef Kantor ED, Udumyan R, Signorello LB, et al. Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk. Gut. 2016;65(8):1289–95.PubMedCrossRef
64.
Zurück zum Zitat Burton A, Martin R, Galobardes B, et al. Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Causes Control. 2010;21(12):2069–77.PubMedCrossRef Burton A, Martin R, Galobardes B, et al. Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Causes Control. 2010;21(12):2069–77.PubMedCrossRef
65.
Zurück zum Zitat Zhang X, Wu K, Giovannucci EL, et al. Early life body fatness and risk of colorectal cancer in U.S. women and men-results from two large cohort studies. Cancer Epidemiol Biomark Prev. 2015;24(4):690–7.CrossRef Zhang X, Wu K, Giovannucci EL, et al. Early life body fatness and risk of colorectal cancer in U.S. women and men-results from two large cohort studies. Cancer Epidemiol Biomark Prev. 2015;24(4):690–7.CrossRef
66.
Zurück zum Zitat Xu J, Galley JD, Bailey MT, et al. The impact of dietary energy intake early in life on the colonic microbiota of adult mice. Sci Rep. 2016;6:19083.PubMedPubMedCentralCrossRef Xu J, Galley JD, Bailey MT, et al. The impact of dietary energy intake early in life on the colonic microbiota of adult mice. Sci Rep. 2016;6:19083.PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat ASMBS estimates of bariatric surgeries. Accessed on 02/06/2017. ASMBS estimates of bariatric surgeries. Accessed on 02/06/2017.
Metadaten
Titel
The Long-term Impact of Roux-en-Y Gastric Bypass on Colorectal Polyp Formation and Relation to Weight Loss Outcomes
verfasst von
Hisham Hussan
Alyssa Drosdak
Melissa Le Roux
Kishan Patel
Kyle Porter
Steven K. Clinton
Brian Focht
Sabrena Noria
Publikationsdatum
23.10.2019
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 2/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04176-w

Weitere Artikel der Ausgabe 2/2020

Obesity Surgery 2/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.